Medication leaflets

Active substance

Results for the substance tirzepatide

18 results

About this active substance

Tirzepatide is a medication used for the treatment of type 2 diabetes. It is a dual agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, meaning it works by stimulating insulin secretion and reducing glucagon production in a glucose-dependent manner.

In addition to blood sugar control, tirzepatide has shown significant benefits in weight reduction and is being investigated for use in obesity treatment. It is administered as a subcutaneous injection, typically once a week.

Side effects may include nausea, vomiting, diarrhea, constipation, or loss of appetite. In rare cases, it may cause pancreatitis or hypoglycemia, especially when used in combination with other antidiabetic medications. It is important for the treatment to be supervised by a healthcare professional.